日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Postoperative SBRT and Severe Late Toxic Effects in Early-Stage Oropharyngeal and Oral Cavity Cancers: The STEREOPOSTOP-GORTEC 2017-03 Nonrandomized Clinical Trial

早期口咽癌和口腔癌术后立体定向放射治疗与严重远期毒性反应：STEREOPOSTOP-GORTEC 2017-03 非随机临床试验

期刊:Jama Network Open
影响因子:9.7
doi:10.1001/jamanetworkopen.2025.49975
Biau, Julian; Sun, Xushan; Liem, Xavier; Faivre, Jean-Christophe; Eker, Elife; Blanchard, Pierre; Tao, Yungan; Doré, Mélanie; Maingon, Philippe; Vulquin, Noémie; Alfonsi, Marc; Thureau, Sebastien; Huguet, Florence; Racadot, Séverine; Thivat, Emilie; Molnar, Ioana; Boisselier, Pierre; Guihard, Sébastien; Gallocher, Olivier; Dupin, Charles; Batard, Stéphanie; Bourhis, Jean; Lapeyre, Michel
肿瘤
肿瘤免疫
TEC
口腔癌
毒理研究
发表日期：2025
文献求助 收藏

Melatonin supplementation for quality of life in older patients with advanced cancer: a randomized controlled trial

褪黑素补充剂对老年晚期癌症患者生活质量的影响：一项随机对照试验

期刊:BMC Geriatrics
影响因子:3.8
doi:10.1186/s12877-025-06899-1
Ginzac, Angeline; Bourbouloux, Emmanuelle; Rivoirard, Romain; Jouannaud, Christelle; Hager, Marie-Odile; Dubois, Sophie; Kwiatkowski, Fabrice; Molnar, Ioana; Thivat, Emilie; Durando, Xavier
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Post-therapeutic support and rehabilitation for breast cancer women in complete remission in a thermal resort: study protocol for the PACThe Real-Life conditions observational trial

在温泉度假村为完全缓解的乳腺癌女性提供治疗后支持和康复：PAC真实世界条件观察性试验的研究方案

期刊:BMC Cancer
影响因子:3.4
doi:10.1186/s12885-025-13524-2
Godiveau, Mélanie; Passildas, Judith; Thivat, Emilie; Casile, Mélanie; Pinard, Céleste; Giro, Alexia; Mouret-Reynier, Marie-Ange; Molnar, Ioana; Abrial, Catherine; Bouvier, Claude-Eugène; Bignon, Yves-Jean; Durando, Xavier
肿瘤
肿瘤免疫
乳腺癌
发表日期：2025
文献求助 收藏

[(99m)Tc]Tc-NTP 15 - 5, a new proteoglycan tracer for functional imaging of joint cartilage: phase I (CARSPECT)

[(99m)Tc]Tc-NTP 15 - 5，一种用于关节软骨功能成像的新型蛋白聚糖示踪剂：I 期（CARSPECT）

期刊:Ejnmmi Research
影响因子:3
doi:10.1186/s13550-025-01318-3
Chanchou, Marion; Thivat, Emilie; Mathieu, Sylvain; Levesque, Sophie; Sas, Nicolas; Auzeloux, Philippe; Billoux, Tommy; Molnar, Ioana; Jouberton, Elodie; Rouanet, Jacques; Fois, Giovanna; Maigne, Lydia; Penault-Llorca, Frédérique; Miot-Noirault, Elisabeth; Durando, Xavier; Cachin, Florent
发表日期：2025
文献求助 收藏

Non-invasive intracranial pressure monitoring for high-grade gliomas patients treated with radiotherapy: results of the GMaPIC trial

对接受放射治疗的高级别胶质瘤患者进行无创颅内压监测：GMaPIC试验结果

期刊:Frontiers in Oncology
影响因子:3.3
doi:10.3389/fonc.2024.1302977
Casile, Mélanie; Thivat, Emilie; Giraudet, Fabrice; Ginzac, Angeline; Molnar, Ioana; Biau, Julian; Brehant, Julien; Lourenco, Blandine; Avan, Paul; Durando, Xavier
胶质瘤
发表日期：2024
文献求助 收藏

NANO-GBM trial of AGuIX nanoparticles with radiotherapy and temozolomide in the treatment of newly diagnosed Glioblastoma: Phase 1b outcomes and MRI-based biodistribution

NANO-GBM试验：AGuIX纳米颗粒联合放疗和替莫唑胺治疗新诊断的胶质母细胞瘤：1b期结果和基于MRI的生物分布

期刊:Clinical and Translational Radiation Oncology
影响因子:2.7
doi:10.1016/j.ctro.2024.100833
Biau, J; Durando, X; Boux, F; Molnar, I; Moreau, J; Leyrat, B; Guillemin, F; Lavielle, A; Cremillieux, Y; Seddik, K; Dufort, S; De Beaumont, O; Thivat, E; Le Duc, G
细胞生物学
发表日期：2024
文献求助 收藏

A phase-II study based on dose adjustment according to UGT1A1 polymorphism: is irinotecan underdosed in first-line FOLFIRI regimen for mCRC?

基于 UGT1A1 多态性剂量调整的 II 期研究：伊立替康在 mCRC 一线 FOLFIRI 方案中剂量是否不足？

期刊:Cancer Chemotherapy and Pharmacology
影响因子:2.3
doi:10.1007/s00280-023-04603-x
Ginzac, Angeline; Thivat, Emilie; Petorin, Caroline; Richard, Damien; Herviou, Pauline; Molnar, Ioana; Devaud, Hervé; Creveaux, Isabelle; Ferrer, Florent; Authier, Nicolas; Jary, Marine; Pezet, Denis; Durando, Xavier
发表日期：2024
文献求助 收藏

Phase I/II study testing the combination of AGuIX nanoparticles with radiochemotherapy and concomitant temozolomide in patients with newly diagnosed glioblastoma (NANO-GBM trial protocol)

I/II 期研究测试 AGuIX 纳米颗粒与放化疗和替莫唑胺联合治疗新诊断的胶质母细胞瘤患者的疗效（NANO-GBM 试验方案）

期刊:BMC Cancer
影响因子:3.4
doi:10.1186/s12885-023-10829-y
Thivat, Emilie; Casile, Mélanie; Moreau, Juliette; Molnar, Ioana; Dufort, Sandrine; Seddik, Khalide; Le Duc, Géraldine; De Beaumont, Olivier; Loeffler, Markus; Durando, Xavier; Biau, Julian
细胞生物学
发表日期：2023
文献求助 收藏

Postoperative SBRT in the treatment of early-stage oropharyngeal and oral cavity cancers with high-risk margins: A dosimetric comparison of volumetric modulated arc therapy with or without non-coplanar arcs and acute toxicity outcomes from the STEREOPOSTOP GORTEC 2017-03 phase 2 trial

早期口咽癌和口腔癌伴高危切缘术后立体定向放射治疗：立体定向放射治疗（VMAT）与非共面弧形治疗的剂量学比较及STEREOPOSTOP GORTEC 2017-03 II期试验的急性毒性结果

期刊:Clinical and Translational Radiation Oncology
影响因子:2.7
doi:10.1016/j.ctro.2022.11.007
Biau, Julian; Lopez, Laura; Thivat, Emilie; Casile, Mélanie; Millardet, Corinne; Saroul, Nicolas; Pham-Dang, Nathalie; Molnar, Ioana; Bourhis, Jean; Lapeyre, Michel
肿瘤
肿瘤免疫
TEC
口腔癌
毒理研究
发表日期：2023
文献求助 收藏

Phase I study of [(131)I] ICF01012, a targeted radionuclide therapy, in metastatic melanoma: MELRIV-1 protocol

[(131)I] ICF01012（一种靶向放射性核素疗法）治疗转移性黑色素瘤的 I 期研究：MELRIV-1 方案

期刊:BMC Cancer
影响因子:3.4
doi:10.1186/s12885-022-09495-3
Thivat, Emilie; Rouanet, Jacques; Auzeloux, Philippe; Sas, Nicolas; Jouberton, Elodie; Levesque, Sophie; Billoux, Tommy; Mansard, Sandrine; Molnar, Ioana; Chanchou, Marion; Fois, Giovanna; Maigne, Lydia; Chezal, Jean-Michel; Miot-Noirault, Elisabeth; D'Incan, Michel; Durando, Xavier; Cachin, Florent
黑色素瘤
发表日期：2022
文献求助 收藏